New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.
The history of revascularization for cardiac ischemia dates back to the early 1960's when the first coronary artery bypass graft procedures were performed in humans. With this 50 year history of providing a new vasculature to ischemic and hibernating myocardium, a profound depth of experience has been amassed in clinical cardiovascular medicine as to what does, and does not work in the context of cardiac revascularization, alleviating ischemia and adequacy of myocardial perfusion. These issues are of central relevance to contemporary cell-based cardiac regenerative approaches. While the cardiovascular cell therapy field is surging forward on many exciting fronts, several well accepted clinical axioms related to the cardiac arterial supply appear to be almost overlooked by some of our current basic conceptual and experimental cell therapy paradigms. We present here information drawn from five decades of the clinical revascularization experience, review relevant new data on vascular formation via cell therapy, and put forward the case that for optimal cell-based cardiac regeneration due attention must be paid to providing an adequate vascular supply.
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Katherine C
KC
Michelis
Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Manfred
M
Boehm
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: jason.kovacic@mountsinai.org.
Jason C
JC
Kovacic
D000818:Animals; D064987:Cell- and Tissue-Based Therapy; D003331:Coronary Vessels / Q000503:physiopathology*; D006321:Heart / Q000503:physiopathology; D006331:Heart Diseases / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D032383:Myocytes, Cardiac / Q000166:cytology*; D018919:Neovascularization, Physiologic; D010477:Perfusion